Columbia University Medical Center - Herbert Irving Comprehensive Cancer Center
New York, New York 10032
We've found
1 trials
at this facility
Metastatic Melanoma Clinical Trial
Updated: 5/29/2014
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling,
Phase
IV
Updated: 5/29/2014
Click here to add this to my saved trials